tiprankstipranks
60 Degrees Pharmaceuticals, Inc. (SXTP)
NASDAQ:SXTP
US Market

60 Degrees Pharmaceuticals, Inc. (SXTP) Financial Statements

21 Followers

60 Degrees Pharmaceuticals, Inc. Financial Overview

60 Degrees Pharmaceuticals, Inc.'s market cap is currently ―. The company's EPS TTM is $-0.659; its P/E ratio is -0.37; 60 Degrees Pharmaceuticals, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 23Dec 22
Income Statement-
Total Revenue$ 21.46K-
Gross Profit$ -51.66K-
EBIT--
EBITDA--
Net Income Common Stockholders$ -2.60M-
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 29.99K$ 264.87K
Total Assets$ 7.59M$ 1.30M
Total Debt$ 24.13M$ 22.45M
Net Debt$ 24.10M$ 22.19M
Total Liabilities$ 27.12M$ 25.45M
Stockholders Equity$ -18.96M$ -23.58M
Cash Flow-
Free Cash Flow$ -412.68K-
Operating Cash Flow$ -412.68K-
Investing Cash Flow$ -3.29K-
Financing Cash Flow$ 182.39K-
Currency in USD

60 Degrees Pharmaceuticals, Inc. Earnings and Revenue History

60 Degrees Pharmaceuticals, Inc. Debt to Assets

60 Degrees Pharmaceuticals, Inc. Cash Flow

60 Degrees Pharmaceuticals, Inc. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis